These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14708423)

  • 1. Suppression of alveolar bone resorption by etidronate treatment for periodontal disease: 4- to 5-year follow-up of four patients.
    Takaishi Y; Ikeo T; Miki T; Nishizawa Y; Morii H
    J Int Med Res; 2003; 31(6):575-84. PubMed ID: 14708423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of etidronate on alveolar pyorrhoea associated with chronic marginal periodontitis: report of four cases.
    Takaishi Y; Miki T; Nishizawa Y; Morii H
    J Int Med Res; 2001; 29(4):355-65. PubMed ID: 11675910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial).
    El-Shinnawi UM; El-Tantawy SI
    J Int Acad Periodontol; 2003 Jan; 5(1):5-10. PubMed ID: 12666950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal assessment of postmenopausal women receiving risedronate.
    Palomo L; Bissada NF; Liu J
    Menopause; 2005; 12(6):685-90. PubMed ID: 16278611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
    Watts NB; Harris ST; Genant HK; Wasnich RD; Miller PD; Jackson RD; Licata AA; Ross P; Woodson GC; Yanover MJ
    N Engl J Med; 1990 Jul; 323(2):73-9. PubMed ID: 2113611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
    Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C
    Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T; McGuigan L; Barbagallo S; Bryant C
    Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T; Kollerup G; Thamsborg G; Genant HK; Sørensen OH
    J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up).
    Meunier PJ; Confavreux E; Tupinon I; Hardouin C; Delmas PD; Balena R
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2784-91. PubMed ID: 9284696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T; Thamsborg G; Steiniche T; Genant HK; Sørensen OH
    N Engl J Med; 1990 May; 322(18):1265-71. PubMed ID: 2109197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S; Matsu K; Uzawa M
    J Orthop Sci; 2003; 8(4):532-7. PubMed ID: 12898306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
    Crilly RG; Sebaldt RJ; Hodsman AB; Adachi JD; Brown JP; Goldsmith CH; Hanley DA; Olszynski WO; Ste-Marie LG; Stephenson GF
    Osteoporos Int; 2000; 11(7):607-14. PubMed ID: 11069195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T; Maekawa S; Morinobu S; Morinobu A; Koshiba M; Yamauchi M; Sugimoto T; Kumagai S
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etidronate].
    Inui K; Takaoka K
    Nihon Rinsho; 2003 Feb; 61(2):226-30. PubMed ID: 12638212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
    Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A
    J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to alendronate in osteoporosis after previous treatment with etidronate.
    Fairney A; Kyd P; Thomas E; Wilson J
    Osteoporos Int; 2000; 11(7):621-5. PubMed ID: 11069197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty.
    Yamaguchi K; Masuhara K; Yamasaki S; Fuji T; Seino Y
    Bone; 2004 Jul; 35(1):217-23. PubMed ID: 15207760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
    Qureshi AM; Herd RJ; Blake GM; Fogelman I; Ralston SH
    Calcif Tissue Int; 2002 Mar; 70(3):158-63. PubMed ID: 11907712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.
    Cetinkaya BO; Keles GC; Ayas B; Gurgor P
    J Periodontol; 2008 Oct; 79(10):1950-61. PubMed ID: 18834251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.